Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Sales | 33,925 | 39,170 | 36,537 | 26,584 | 15,967 |
| Gross Profit | 33,925 | 39,170 | 36,537 | 26,584 | 15,967 |
| Operating Expenses | 76,984 | 71,710 | 64,018 | 51,899 | 38,577 |
| Operating Income | -43,059 | -32,540 | -27,481 | -25,315 | -22,610 |
| Interest Expense | 11,424 | 9,350 | 3,585 | 1,206 | 1,102 |
| Other Income | -4,742 | -1,090 | 0 | 0 | 0 |
| Pre-tax Income | -59,225 | -42,980 | -31,066 | -26,521 | -23,712 |
| Net Income Continuous | -59,225 | -37,745 | -31,066 | -26,521 | -23,712 |
| Net Income | $-59,225 | $-42,980 | $-31,066 | $-26,521 | $-23,712 |
| EPS Basic Total Ops | -2.08 | -1.60 | -1.17 | -1.04 | -1.10 |
| EPS Basic Continuous Ops | -2.06 | -1.40 | -1.17 | -1.04 | -1.10 |
| EPS Diluted Total Ops | -2.08 | -1.60 | -1.17 | -1.04 | -1.10 |
| EPS Diluted Continuous Ops | -2.06 | -1.40 | -1.17 | -1.04 | -1.10 |
| EBITDA(a) | $-37,863 | $-28,290 | $-24,303 | $-22,682 | $-19,796 |